Timothy Hinks
banner
hinkslab.bsky.social
Timothy Hinks
@hinkslab.bsky.social
The Hinks Lab investigate the immunopathogenesis of airway diseases and pulmonary infections.
Simon and Fleur's new paper is out in The Lancet Respiratory Medicine!
ORACLE2 pooled 6,500+ asthma patients from 22 RCTs.
🧪 Blood eosinophils + FeNO = key predictors of asthma attacks
💨 Reversibility = lower risk?
Open access: www.thelancet.com/journals/lan...
#asthma #ORACLE2
Inflammatory and clinical risk factors for asthma attacks (ORACLE2): a patient-level meta-analysis of control groups of 22 randomised trials
Blood eosinophil count, FeNO, asthma attack history, disease severity, low lung function (low FEV1%), and symptoms (ACQ-5 score) are key predictors of asthma attacks. Conversely, we found that moderat...
www.thelancet.com
April 10, 2025 at 9:24 AM
Out today - a new role for MAIT cells. We've shown MAIT cells are antibacterial; antiviral; and promote tissue repair. In this paper from our group we show MAIT cells are recruited and activated to protect tissues in sterile lung injury, and potentially in IPF - enjoy!
doi.org/10.1016/j.ce...
February 7, 2025 at 8:27 AM
Reposted by Timothy Hinks
1st post on Bluesky! Lovely little highlight of our recent publication by Adam Williams and Kelly Butler. Thanks for the fantastic summary! www.science.org/doi/10.1126/...
It’s the little things in life: Lymph node microniches drive TH2 formation in allergic asthma
Lymph node IL-2 microniches guide development of TH2 cells through induction of Blimp-1 expression and an IL-10–positive feedback loop.
www.science.org
December 20, 2024 at 9:06 PM
The 'Dream Combo' in #EosinophilicAsthma: for those on #asthma biologics with persistent mucopurulent cough additional long term, low dose azithromycin is highly effective. Gabriel's findings from @OxfordBRC out today in thorax.bmj.com/content/earl...
December 20, 2024 at 8:40 AM
Reposted by Timothy Hinks
This has taken such a long time to retract - the fraudulent study on potential of hydroxychloroquine as a COVID-19 treatment has done so much harm however not sure the incoming trump administration will take any note 😔🧪 www.science.org/content/arti...
Infamous paper that popularized unproven COVID-19 treatment finally retracted
Study on hydroxychloroquine by Didier Raoult and colleagues gets pulled on ethical and scientific grounds
www.science.org
December 17, 2024 at 9:09 PM
The new NICE/BTS/SIGN #Asthma guidelines are superb. A collaborative approach. A focus on using blood eos and FeNO at initial presentation and finally the long-overdue end to salbutamol. Read it and use it now www.nice.org.uk/guidance/NG245
Overview | Asthma: diagnosis, monitoring and chronic asthma management (BTS, NICE, SIGN) | Guidance | NICE
www.nice.org.uk
November 28, 2024 at 9:31 AM
Wonderful to see Imran Howell announced this year's BTS Young Investigator Award winner for delivering the BOOST trial. Well deserved!
November 27, 2024 at 4:35 PM
When exacerbations of severe #asthma occur despite being on type 2 biologics, what residual inflammation remains? In our latest paper from @OxfordBRC we show prednisolone caused broad down regulation of type 2 pathways in pts on mepolizumab.
Full report: doi.org/10.1016/j.ja...
November 15, 2024 at 9:53 PM
1 million people joined BlueSky today. Feels like time to exit X. Thanks for finding us here!
November 15, 2024 at 9:51 PM
Editors pick this month in Allergy - Our new species-level study from @OxfordBRC shows severe #asthma microbiome is dominated by H. influenzae, M. catarrhalis and S. pneumoniae, driving
neutrophilic inflammation, airway proteases and disrupting regulatory immune responses: doi.org/10.1111/all....
Species‐level, metagenomic and proteomic analysis of microbe‐immune interactions in severe asthma
Paired long-read metagenomic sequencing and proteomics in sputum and nasal lavage identified a single dominant respiratory pathogen (H. influenzae more than M. catarrhalis and S. pneumoniae) in 23% o...
doi.org
November 15, 2024 at 9:50 PM